RADNOR, Pa., Feb. 27, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP reminds iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) investors that a securities fraud class action lawsuit has been filed against iRhythm on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive […]
Financial
PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors
NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) — PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that the Advanced Medical Technology Association (AdvaMed), the world’s leading medical technology trade association, has appointed Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive […]
Ontrak Pre-Announces 2020 Fourth Quarter and Year End Financial Results
Record Quarterly Revenue of $29.3 million in Q4 2020, up 149% year over year and up 22% from Q3 2020 Operating loss of $1.8 million in Q4 2020, a 74% improvement year over year Record Quarterly Adjusted EBITDA of $2.2 million in Q4 2020, achieving quarterly positive Adjusted EBITDA for […]
Tenaya Therapeutics Secures $106 Million in Series C Funding to Accelerate Pipeline of Potentially Curative Therapies for Heart Disease
Series C round led by RTW Investments, LP; RA Capital Management; Fidelity Management & Research Company; and funds and accounts advised by T. Rowe Price Associates, Inc.; and joined by existing investors including The Column Group, Casdin Capital and GV. Funds will help advance lead gene therapy program in hypertrophic […]
Nihon Kohden Rebrands Nihon Kohden USLab as Nihon Kohden Digital Health Solutions Inc.
Reflects Company’s Evolution to Offering Digital Health Framework Complementing its Capital Equipment Technologies IRVINE, Calif.–(BUSINESS WIRE)–Nihon Kohden, a U.S. market leader in precision medical products and services, today announced that it is rebranding Nihon Kohden USLab, its Irvine-based R&D and product development subsidiary, to Nihon Kohden Digital Health Solutions Inc. […]
Zynex Announces 2020 Fourth Quarter and Full Year Earnings
ENGLEWOOD, Colo., Feb. 25, 2021 /PRNewswire/ — 2020 Full Year Revenue increased 76% year over year to $80.1 million Orders increased 96% Net income of $9.1 million; Diluted EPS $0.26 Adjusted EBITDA $13.7 millio 2020 Revenue and Adjusted EBITDA are the highest in Company history 2020 Fourth Quarter Revenue increased 81% year over year to $25.6 million Orders […]
iRhythm Technologies Announces Fourth Quarter and Full Year 2020 Financial Results
SAN FRANCISCO, Feb. 25, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months and full year ended December 31, 2020. Fourth Quarter 2020 Financial Highlights Revenue of $78.8 million […]
Cytokinetics Reports Fourth Quarter 2020 Financial Results
Company Plans to Meet with FDA in Q1 to Discuss Results of GALACTIC-HF Enrollment Completed in Cohort 2 of REDWOOD-HCM; Results Expected Mid-Year Company Provides 2021 Financial Guidance; More Than Two Years of Cash Runway SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) reported […]
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Company demonstrates resilience despite COVID-19 challenges: Financial situation secure and development programs progressing Conference call begins today at 4:30 p.m. (ET) BASKING RIDGE, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies […]
Acceleron Reports Fourth Quarter and Full Year 2020 Financial Results
– Updates from ongoing PULSAR and SPECTRA Phase 2 clinical trials of sotatercept in patients with pulmonary arterial hypertension (PAH) presented at the American Heart Association (AHA) 2020 Scientific Sessions – – STELLAR Phase 3 trial initiated with sotatercept in PAH – – Acceleron recognized approximately $23.0 million in royalty […]
Recent
Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)
Curium, in collaboration with nuclear cardiology leaders, announces immediate return of Thallous Chloride TI 201 Injection in the U.S. to support high-stakes cardiac imaging needs
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors
Popular
- No commented posts yet